FDA Letter To Industry

You may submit written comments regarding this guidance at any time. Submit writtn comments on the guidance to the Division of Dockets Management (HFA- 350), Food and Drug Administration, 5630 Fisher Lane, rm. 1061 Rockville, MD 20852. All comments should be identified with the tittle of the guidance document.